Published in Nat Biotechnol on February 01, 2000
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest (2001) 1.63
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. AAPS J (2009) 1.48
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells. J Allergy Clin Immunol (2014) 1.47
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Ther Clin Risk Manag (2007) 1.11
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. Multidiscip Respir Med (2014) 0.99
Conformational flexibility in immunoglobulin E-Fc 3-4 revealed in multiple crystal forms. J Mol Biol (2009) 0.94
Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor. Nature (2012) 0.93
Advances in anti-IgE therapy. Biomed Res Int (2015) 0.88
Severe asthma: anti-IgE or anti-IL-5? Eur Clin Respir J (2016) 0.86
An overview of the effects of anti-IgE therapies. Med Sci Monit (2014) 0.84
Omalizumab: a monoclonal anti-IgE antibody. MedGenMed (2005) 0.82
Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo. J Biol Chem (2008) 0.81
Severe asthma and the omalizumab option. Clin Mol Allergy (2008) 0.80
Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5). Int J Biomed Sci (2009) 0.79
Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells. Clin Transl Allergy (2013) 0.79
Structure of the omalizumab Fab. Acta Crystallogr F Struct Biol Commun (2015) 0.78
Bacterial expression and characterization of a novel human anti-IgE scFv fragment. MAbs (2011) 0.78
The future of biologics: applications for food allergy. J Allergy Clin Immunol (2015) 0.77
Developing therapies for peanut allergy. Int Arch Allergy Immunol (2014) 0.76
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments. J Immunol Res (2016) 0.75
What Taiwan contributes to the world of allergy and clinical immunology? Asia Pac Allergy (2013) 0.75
Cytomegalic hepatitis in a patient receiving omalizumab. IDCases (2016) 0.75
The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy. Curr Allergy Asthma Rep (2016) 0.75
From IgE to Omalizumab. J Immunol (2016) 0.75
Skewed Exposure to Environmental Antigens Complements Hygiene Hypothesis in Explaining the Rise of Allergy. Acta Biotheor (2017) 0.75
Is there a role for treatment of asthma with omalizumab? Arch Dis Child (2003) 0.75
Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels. Allergy Asthma Immunol Res (2015) 0.75